Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Solesence (SLSN) EBT Margin (2016 - 2025)

Historic EBT Margin for Solesence (SLSN) over the last 16 years, with Q3 2025 value amounting to 7.67%.

  • Solesence's EBT Margin fell 257300.0% to 7.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.71%, marking a year-over-year decrease of 28800.0%. This contributed to the annual value of 8.52% for FY2024, which is 202800.0% up from last year.
  • According to the latest figures from Q3 2025, Solesence's EBT Margin is 7.67%, which was down 257300.0% from 15.02% recorded in Q2 2025.
  • Solesence's 5-year EBT Margin high stood at 18.52% for Q1 2021, and its period low was 26.49% during Q4 2023.
  • Its 5-year average for EBT Margin is 0.76%, with a median of 0.55% in 2025.
  • Its EBT Margin has fluctuated over the past 5 years, first skyrocketed by 361000bps in 2024, then crashed by -257300bps in 2025.
  • Quarter analysis of 5 years shows Solesence's EBT Margin stood at 4.85% in 2021, then crashed by -400bps to 24.23% in 2022, then fell by -9bps to 26.49% in 2023, then skyrocketed by 90bps to 2.63% in 2024, then tumbled by -191bps to 7.67% in 2025.
  • Its last three reported values are 7.67% in Q3 2025, 15.02% for Q2 2025, and 0.55% during Q1 2025.